CA2974191A1 - Identification of epigenetic biomarkers in the saliva of children with autism spectrum disorder - Google Patents

Identification of epigenetic biomarkers in the saliva of children with autism spectrum disorder Download PDF

Info

Publication number
CA2974191A1
CA2974191A1 CA2974191A CA2974191A CA2974191A1 CA 2974191 A1 CA2974191 A1 CA 2974191A1 CA 2974191 A CA2974191 A CA 2974191A CA 2974191 A CA2974191 A CA 2974191A CA 2974191 A1 CA2974191 A1 CA 2974191A1
Authority
CA
Canada
Prior art keywords
subject
biological sample
mirna
collection
asd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2974191A
Other languages
English (en)
French (fr)
Inventor
Steven D. Hicks
Frank A. Middleton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of the State University of New York filed Critical Research Foundation of the State University of New York
Publication of CA2974191A1 publication Critical patent/CA2974191A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CA2974191A 2015-01-21 2016-01-20 Identification of epigenetic biomarkers in the saliva of children with autism spectrum disorder Abandoned CA2974191A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562106107P 2015-01-21 2015-01-21
US62/106,107 2015-01-21
US201562263467P 2015-12-04 2015-12-04
US62/263,467 2015-12-04
PCT/US2016/014182 WO2016118662A1 (en) 2015-01-21 2016-01-20 Identification of epigenetic biomarkers in the saliva of children with autism spectrum disorder

Publications (1)

Publication Number Publication Date
CA2974191A1 true CA2974191A1 (en) 2016-07-28

Family

ID=56417707

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2974191A Abandoned CA2974191A1 (en) 2015-01-21 2016-01-20 Identification of epigenetic biomarkers in the saliva of children with autism spectrum disorder

Country Status (5)

Country Link
US (1) US20180171406A1 (enExample)
EP (1) EP3247798A4 (enExample)
JP (1) JP2018504123A (enExample)
CA (1) CA2974191A1 (enExample)
WO (1) WO2016118662A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3601563A4 (en) * 2017-03-21 2021-04-14 Quadrant Biosciences Inc. AUTISTIC SPECTRUM DISORDER ANALYSIS
WO2018175422A1 (en) * 2017-03-23 2018-09-27 Quadrant Biosciences Inc. Method for diagnosing or monitoring conditions characterized by abnormal temporal variations method of normalizing epigenetic data to compensate for temporal variations
WO2018175941A1 (en) * 2017-03-23 2018-09-27 Quadrant Biosciences Inc. Analysis and prediction of traumatic brain injury and concusion symptoms
US20230295728A1 (en) * 2020-06-04 2023-09-21 Centre National De La Recherche Scientifique (Cnrs) Methods for diagnosing and treating autism

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100202973A1 (en) * 2007-05-18 2010-08-12 Karolinska Institutet Innovations Ab Microrna molecules associated with inflammatory skin disorders
WO2008154098A2 (en) * 2007-06-07 2008-12-18 Wisconsin Alumni Research Foundation Reagents and methods for mirna expression analysis and identification of cancer biomarkers
WO2011079299A1 (en) * 2009-12-23 2011-06-30 The George Washington University Compositions and methods for identifying autism spectrum disorders

Also Published As

Publication number Publication date
JP2018504123A (ja) 2018-02-15
WO2016118662A1 (en) 2016-07-28
EP3247798A4 (en) 2019-01-02
EP3247798A1 (en) 2017-11-29
US20180171406A1 (en) 2018-06-21

Similar Documents

Publication Publication Date Title
Hicks et al. Salivary miRNA profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate ASD candidate genes involved in neurodevelopment
Shen et al. Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
Fransquet et al. Micro RNA as a potential blood-based epigenetic biomarker for Alzheimer's disease
Hicks et al. Validation of a salivary RNA test for childhood autism spectrum disorder
US20130123124A1 (en) Methods and compositions for characterizing autism spectrum disorder based on gene expression patterns
KR102359013B1 (ko) 자폐 스펙트럼 장애의 분석
US20220145354A1 (en) Method and system for predicting response of a subject to antidepressant treatment
KR102621064B1 (ko) 외상성 뇌 손상 및 뇌진탕 증상의 분석 및 예측
JP2012501181A (ja) バイオマーカー・プロファイルを測定するためのシステムおよび方法
Clelland et al. Utilization of never-medicated bipolar disorder patients towards development and validation of a peripheral biomarker profile
JP2023518291A (ja) 循環遊離ｍＲＮＡプロファイリングアッセイを使用してアルツハイマー病のリスクを検出するシステムおよび方法
US20180171406A1 (en) Identification of epigenetic biomarkers in the saliva of children with autism spectrum disorder
CN114514329A (zh) 治疗或预防方法
WO2021230379A1 (ja) パーキンソン病の検出方法
JP2022520427A (ja) 脳損傷の唾液バイオマーカー
EP3294933A1 (en) Systems and methods to predict autism before onset of behavioral symptoms and/or to diagnose autism
CN113195738A (zh) 识别患有川崎病的受试者的方法
EP3149208B1 (en) Genetic markers for memory loss
von Deimling et al. Gene expression analysis in untreated absence epilepsy demonstrates an inconsistent pattern
CN115181798A (zh) 帕金森病认知障碍标志物及基于该标志物的疾病预测模型的构建方法与应用
US20230109065A1 (en) Methods for diagnosis and prediction of genetic diseases and phenotypes from lgd mutations
US20160340730A1 (en) Methods for evaluating neurological disease
Chaves et al. A Cohort Study of Individuals with Neurodevelopmental Disorders and/or Congenital Anomalies Investigated by High-Resolution Chromosomal Microarrays in Southern Brazil: The Significance of Autism Spectrum Disorder
WO2025039033A1 (en) Methods and reagents for diagnosis and/or prognosis of traumatic brain injury
CN119020481A (zh) 检测xcl2基因表达的物质在制备检测帕金森病产品中的应用

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20220412

FZDE Discontinued

Effective date: 20220412

FZDE Discontinued

Effective date: 20220412